BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16049965)

  • 1. Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers.
    Hienonen T; Salovaara R; Mecklin JP; Järvinen H; Karhu A; Aaltonen LA
    Int J Cancer; 2006 Jan; 118(2):505-8. PubMed ID: 16049965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional polymorphism 57Val>Ile of aurora kinase A associated with increased risk of gastric cancer progression.
    Ju H; Cho H; Kim YS; Kim WH; Ihm C; Noh SM; Kim JB; Hahn DS; Choi BY; Kang C
    Cancer Lett; 2006 Oct; 242(2):273-9. PubMed ID: 16412566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate.
    Matarasso N; Bar-Shira A; Rozovski U; Rosner S; Orr-Urtreger A
    Neoplasia; 2007 Sep; 9(9):707-15. PubMed ID: 17898866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide allelotyping of 104 Finnish colorectal cancers reveals an excess of allelic imbalance in chromosome 20q in familial cases.
    Laiho P; Hienonen T; Karhu A; Lipton L; Aalto Y; Thomas HJ; Birkenkamp-Demtroder K; Hodgson S; Salovaara R; Mecklin JP; Järvinen H; Knuutila S; Halford S; Ørntoft TF; Tomlinson I; Launonen V; Houlston R; Aaltonen LA
    Oncogene; 2003 Apr; 22(14):2206-14. PubMed ID: 12687022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutations.
    Vidarsdottir L; Bodvarsdottir SK; Hilmarsdottir H; Tryggvadottir L; Eyfjord JE
    Cancer Lett; 2007 Jun; 250(2):206-12. PubMed ID: 17113223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHEK2 I157T associates with familial and sporadic colorectal cancer.
    Kilpivaara O; Alhopuro P; Vahteristo P; Aaltonen LA; Nevanlinna H
    J Med Genet; 2006 Jul; 43(7):e34. PubMed ID: 16816021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number increase of aurora kinase A in colorectal cancers: a correlation with tumor progression.
    Zhang C; Fang Z; Xiong Y; Li J; Liu L; Li M; Zhang W; Wan J
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):834-8. PubMed ID: 20929925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage disequilibrium and haplotype analysis of two single nucleotide polymorphisms in STK15 in Chinese.
    Chen L; Ao X; Ren Q; Wang ZN; Lu C; Xu Y; Jiang L; Luo Y; Xu HM; Zhang X
    Yi Chuan Xue Bao; 2005 Apr; 32(4):331-6. PubMed ID: 16011022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic search for rare variants in Finnish early-onset colorectal cancer patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Järvinen H; Mecklin JP; Böhm J; Kilpivaara O; Pitkänen E; Palin K; Vahteristo P; Tuupanen S; Aaltonen LA
    Cancer Genet; 2015; 208(1-2):35-40. PubMed ID: 25749350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.
    Ewart-Toland A; Dai Q; Gao YT; Nagase H; Dunlop MG; Farrington SM; Barnetson RA; Anton-Culver H; Peel D; Ziogas A; Lin D; Miao X; Sun T; Ostrander EA; Stanford JL; Langlois M; Chan JM; Yuan J; Harris CC; Bowman ED; Clayman GL; Lippman SM; Lee JJ; Zheng W; Balmain A
    Carcinogenesis; 2005 Aug; 26(8):1368-73. PubMed ID: 15802297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two functional coding single nucleotide polymorphisms in STK15 (Aurora-A) coordinately increase esophageal cancer risk.
    Kimura MT; Mori T; Conroy J; Nowak NJ; Satomi S; Tamai K; Nagase H
    Cancer Res; 2005 May; 65(9):3548-54. PubMed ID: 15867347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common genetic polymorphisms of AURKA and prostate cancer risk.
    Feik E; Baierl A; Madersbacher S; Schatzl G; Maj-Hes A; Berges R; Micksche M; Gsur A
    Cancer Causes Control; 2009 Mar; 20(2):147-52. PubMed ID: 18802780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Never in mitosis gene A-related kinase 6 and aurora kinase A: New gene biomarkers in the conversion from ulcerative colitis to colorectal cancer.
    Gerçeker E; Boyacıoglu SO; Kasap E; Baykan A; Yuceyar H; Yıldırım H; Ayhan S; Ellidokuz E; Korkmaz M
    Oncol Rep; 2015 Oct; 34(4):1905-14. PubMed ID: 26259750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aurora-A gene is frequently amplified in basal-like breast cancer.
    Staff S; Isola J; Jumppanen M; Tanner M
    Oncol Rep; 2010 Feb; 23(2):307-12. PubMed ID: 20043089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer and the CHEK2 1100delC mutation.
    de Jong MM; Nolte IM; Te Meerman GJ; van der Graaf WT; Mulder MJ; van der Steege G; Bruinenberg M; Schaapveld M; Niessen RC; Berends MJ; Sijmons RH; Hofstra RM; de Vries EG; Kleibeuker JH
    Genes Chromosomes Cancer; 2005 Aug; 43(4):377-82. PubMed ID: 15852425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
    Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Colman H; Le Neel T; Le Houérou C; Faroux R; Ollivry J; Lafraise B; Chupin LD; Sébille V; Bézieau S
    BMC Cancer; 2008 Nov; 8():326. PubMed ID: 18992148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
    Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.
    Mao X; Hamoudi RA; Talbot IC; Baudis M
    Cancer Genet Cytogenet; 2006 May; 167(1):1-14. PubMed ID: 16682279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells.
    Chung CM; Man C; Jin Y; Jin C; Guan XY; Wang Q; Wan TS; Cheung AL; Tsao SW
    Mol Carcinog; 2005 Jul; 43(3):165-74. PubMed ID: 15880741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
    Mosquera JM; Beltran H; Park K; MacDonald TY; Robinson BD; Tagawa ST; Perner S; Bismar TA; Erbersdobler A; Dhir R; Nelson JB; Nanus DM; Rubin MA
    Neoplasia; 2013 Jan; 15(1):1-10. PubMed ID: 23358695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.